Gyeonggi-do, South Korea

Borami Jeon

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qurient Co., Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Borami Jeon: Innovator in Topical Anti-Inflammatory Treatments

Introduction

Borami Jeon is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative treatments for inflammation. His work focuses on creating effective topical solutions that can alleviate various inflammatory conditions.

Latest Patents

Borami Jeon holds 1 patent for a topical anti-inflammatory pharmaceutical composition comprising Zileuton. This invention relates to a formulation that not only provides anti-inflammatory benefits but also outlines methods for preparing such compositions. The potential applications of this invention could greatly enhance the treatment options available for patients suffering from inflammatory disorders.

Career Highlights

Throughout his career, Borami Jeon has been associated with Qurient Co., Ltd., a company dedicated to advancing pharmaceutical innovations. His role at Qurient has allowed him to focus on research and development, contributing to the company's mission of improving healthcare through innovative solutions.

Collaborations

Borami has collaborated with talented individuals such as Kiyean Nam and Jaeseung Kim. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in their field.

Conclusion

Borami Jeon is a distinguished inventor whose work in topical anti-inflammatory treatments showcases his commitment to improving patient care. His innovative approach and collaboration with skilled colleagues position him as a key figure in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…